Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers

Rebouissou et al. recently provided preclinical evidence that a subset of patients with muscle-invasive bladder cancer might benefit from anti-epidermal growth factor receptor (EGFR) therapy and reported diagnostic tools for identifying these patients in the clinical setting. This work also identifi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cell Oncol
Main Authors: Lebret, Thierry, Neuzillet, Yann, Houede, Nadine, Rebouissou, Sandra, Bernard-Pierrot, Isabelle, De Reynies, Aurélien, Benhamou, Simone, Allory, Yves, Radvanyi, François
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Author's View
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905367/
https://ncbi.nlm.nih.gov/pubmed/27308521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2014.999507
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados